[Form 4] IZEA Worldwide, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Antonio Bonchristiano, a director of IZEA Worldwide, acquired 4,032 shares of IZEA common stock as restricted stock on September 30, 2025 in payment of Q3 2025 director fees. The award was valued at $15,000 using the closing price of $3.72 on the grant date and vested immediately. After the transaction, Bonchristiano beneficially owned 23,985 shares. The Form 4 was filed by one reporting person and signed on behalf of Bonchristiano by an attorney-in-fact on October 1, 2025. This disclosure reports a routine, non-derivative compensation-related grant to a company director.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director compensation paid in restricted stock; vests immediately and modestly increases insider ownership.
This Form 4 documents a standard director fee settlement using restricted common stock rather than cash. The award amount, $15,000, and the share count, 4,032, are modest relative to typical market-capitalized equity grants and the award vested immediately, removing future vesting risk. Immediate vesting is governance-relevant because it converts a contingent award into outright shares at grant, slightly increasing the director's direct ownership to 23,985 shares. There is no indication of derivative transactions, cash sales, or other compensatory arrangements in this filing.
TL;DR: Filings and signatures appear standard; transaction properly reported as required under Section 16.
The Form 4 shows the transaction date of 09/30/2025 and a signature executed by an attorney-in-fact on 10/01/2025. The report specifies the transaction code as an acquisition for director fees and provides the valuation method (closing price of $3.72). From a compliance standpoint, the report contains the necessary fields for a non-derivative compensation grant and identifies the filer as a director. No amendments or additional disclosures are present in this filing.